CDKN2B-AS1 and atherosclerosis: To identify the in vivo role and mechanism of ANRIL in atherosclerosis, we developed transgenic mice with the overexpression of ANRIL (full-length NR_003529) and crossed these mice to ApoE−/− mice, resulting in ApoE−/−ANRIL mice.